RYAN SPECIALTY HOLDINGS, INC. — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Ryan Specialty reported Q2 2026 revenue of $916.6M (+7.2% YoY), with organic growth of 6.7%. Net income fell 13.1% to $108.4M ($0.33 diluted EPS) due to higher operating expenses (up 10.9%), though adjusted EBITDAC grew 6.0% to $326.9M and adjusted diluted EPS rose 12.1% to $0.74. The company repurchased 8.1M shares ($260M) and raised its $300M buyback authorization. Adjusted EBITDAC margin compressed 40bp to 35.7%. Management guided to mid-single-digit organic growth and flagged 50–100bp margin headwind for full-year 2026.
Why this rating
Solid organic growth offsetting margin compression; modest absolute impact relative to $8.6B market cap; no material M&A or strategic shift.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.